SOLAI Limited Receives Continued Listing Notice from NYSE; Announces Changes to its Board of Directors

Rhea-AI Summary

SOLAI (NYSE: SLAI) received a continued listing notice from the NYSE on Jan 29, 2026 for failing to maintain a US$1.00 average ADS closing price over a consecutive 30 trading-day period ending Jan 28, 2026. The company has a six-month cure period to regain compliance.

SOLAI notified the NYSE of its intent to regain compliance on Feb 10, 2026. The ADSs remain listed and traded while the company meets other NYSE standards. The Board also announced the resignation of independent director Qian Sun and the immediate appointment of independent director Zhan Chen, who will join three board committees.

Positive

• Company has a defined six-month cure period to regain compliance
• SOLAI remains listed and traded on NYSE during the cure period
• New independent director Zhan Chen appointed to audit, nominating, and strategy committees

Negative

• Average ADS closing price fell below US$1.00 over a 30 trading-day period ending Jan 28, 2026
• NYSE notified company of noncompliance on Jan 29, 2026, triggering potential delisting if not cured

News Market Reaction – SLAI

+2.48%

1 alert

+2.48% News Effect

+$357K Valuation Impact

$15M Market Cap

0.1x Rel. Volume

On the day this news was published, SLAI gained 2.48%, reflecting a moderate positive market reaction. This price movement added approximately $357K to the company's valuation, bringing the market cap to $15M at that time.

Data tracked by StockTitan Argus on the day of publication.

AKRON, Ohio, Feb. 27, 2026 /PRNewswire/ -- SOLAI Limited (NYSE: SLAI) (previously traded under "BTCM") ("SOLAI" or the "Company"), a leading technology-driven cryptocurrency infrastructure company, today announced that on January 29, 2026, the Company was notified by the New York Stock Exchange ("NYSE") that it is not in compliance with continued listing standards set forth in Section 802.01C of the NYSE Listed Company Manual because as of January 28, 2026, the average closing price of the Company's American Depositary Shares ("ADSs") was less than US$1.00 per ADS over a consecutive 30 trading-day period.

The Company notified the NYSE on February 10, 2026, of its intent to regain compliance with the minimum price requirement.

The Company has six months ("the Cure Period") following receipt of the notice to regain compliance with the minimum share price requirement. The Company can regain compliance at any time during the six-month Cure Period if, on the last trading day of any calendar month during the Cure Period, its ADSs have a closing price of at least US$1.00 and an average closing price of at least US$1.00 over the 30 consecutive trading-day period ending on the last trading day of that month. If such compliance with the minimum share price requirement has not been regained by the end of the Cure Period, the NYSE will commence suspension and delisting procedures.

The notice has no immediate impact on the listing of the Company's ADSs, which will continue to be listed and traded on the NYSE, subject to compliance with other NYSE continued listing standards and other rights of the NYSE to delist the ADSs. The Company is currently in compliance with all other NYSE continued listing standards. The notice does not affect the Company's business operations, its U.S. Securities and Exchange Commission reporting requirements or contractual obligations. The Company is closely monitoring the closing price of its ADSs and intends to regain compliance.

Changes to Board of Directors

The Company also announced that Mr. Qian Sun has resigned as an independent director, effective immediately. Mr. Sun's resignation is for personal reasons and does not involve any disagreement with the Company's Board of Directors (the "Board"). Mr. Sun expressed his gratitude for the opportunity to serve the Company and wished it continued success.

Concurrently, SOLAI appointed Mr. Zhan Chen as an independent director of the Company, effective immediately. Mr. Chen satisfies the requirements for an "independent director" within the meaning of Section 303A of the Corporate Governance Rules of the NYSE, and meets the criteria for independence set forth in Rule 10A-3 of the Securities Exchange Act of 1934, as amended. Mr. Chen will succeed Mr. Sun as a member of the audit committee, the nominating and corporate governance committee, and the strategy committee of the Board.

Mr. Chen brings extensive entrepreneurial and executive leadership experience across the consumer, technology, and fintech sectors in both the U.S. and Asia. He is the founder and, since 2025, the CEO of Open Mouth Food Inc., a U.S.-based premium food company specializing in clean-label, shelf-stable Asian noodle soups and broths. Previously, Mr. Chen successfully founded and scaled multiple ventures, serving as CEO of Boba Labs Inc. from 2022 to 2024 and Qin Yan Tech from 2017 to 2019. Earlier in his career, he served as CEO of the consumer lending division at Wheat Financial Technology. Mr. Chen received a bachelor's degree from the East China University of Political Science and Law. He is an alumnus of Tsinghua University's Global Entrepreneur Leadership Program at the PBC School of Finance, a curriculum tailored for founders, entrepreneurs, and senior investment professionals driving innovative, high-growth ventures. He also completed an executive education program at China Europe International Business School ("CEIBS").

Mr. Bo Yu, the Chairman of the Board and Chief Operating Officer of SOLAI, commented, "On behalf of the Board and the entire management team, I would like to extend our deepest gratitude to Mr. Sun for his invaluable guidance and dedicated service since 2013. We wish him the absolute best in his future endeavors as he returns to his commitments at HSG. As we develop our strategy, infrastructure, and products to drive the next phase of growth, we are very excited to welcome Mr. Chen to the Board. His proven leadership and dynamic entrepreneurial track record having founded and scaled ventures across the consumer, fintech, and broader technology sectors will bring fresh, highly relevant perspectives to the Board."

About SOLAI Limited

SOLAI Limited (previously known as "BIT Mining Limited") (NYSE: SLAI) (previously traded under "BTCM"), is a technology-driven cryptocurrency infrastructure company expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins and payment infrastructure, and Solana treasury and staking operations — supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. By leveraging its blockchain and data infrastructure expertise, SOLAI aims to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "going forward," "outlook" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Important factors that could cause SOLAI's actual results to differ materially from those indicated in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

For further information:

SOLAI Limited
ir@solai.com
ir.solai.com
www.solai.com

Christensen Advisory
Jason Ng
Tel: +852-2117-0861
Email: solai@christensencomms.com

 

View original content:https://www.prnewswire.com/news-releases/solai-limited-receives-continued-listing-notice-from-nyse-announces-changes-to-its-board-of-directors-302699630.html

SOURCE SOLAI Limited

FAQ

What does the NYSE continued listing notice mean for SOLAI (SLAI) shareholders?

It means SOLAI received a notice for ADSs trading below the $1.00 threshold and must cure within six months. According to the company, the notice relates to a 30 trading-day average below US$1.00 and does not immediately affect listing status.

How long does SOLAI (SLAI) have to regain NYSE compliance after the Jan 29, 2026 notice?

SOLAI has a six-month cure period from receipt of the notice to regain the minimum price standard. According to the company, compliance can be restored if the ADSs meet the $1.00 closing and 30-day average test on a month-end trading day.

Are SOLAI ADSs (SLAI) still trading after the NYSE notice dated Jan 29, 2026?

Yes, SOLAI ADSs continue to be listed and traded on the NYSE while the company pursues compliance. According to the company, the notice does not have an immediate impact on trading and other listing standards still apply.

Who left and who joined SOLAI's board as announced Feb 27, 2026 for SLAI?

Independent director Qian Sun resigned and Zhan Chen was appointed effective immediately. According to the company, Mr. Chen meets NYSE independence criteria and will serve on the audit, nominating and corporate governance, and strategy committees.

What steps has SOLAI (SLAI) taken after receiving the NYSE noncompliance notice?

SOLAI notified the NYSE of its intent to regain compliance on Feb 10, 2026 and is monitoring ADS closing prices. According to the company, it intends to regain compliance during the six-month cure period and remains compliant with other NYSE standards.